ARCHIVES

FDA Approves Generic Oncology Injectable Currently In Shortage

This article is from The Cancer Letter archive.

Vol. 39 No. 36 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

BMS Demands Resignation Of Two ImClone Executives

February 8, 2002

Announcement, RFA On Drug Discovery Groups Coming

December 10, 1982

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

Cancer center directors to develop blueprint for progress that’s “honest,” M.D. Anderson’s John Mendelsohn says.

November 23, 2005

Biotheraputices To Reveal Plans for Expansion

August 8, 1986

In Brief: Frederickson Resigns As NIH Director, Says He Wants “One More Career: As Scientist, Physician

June 25, 1981